Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enteroviruses are a genus of small, non-enveloped, positive-sense single-stranded RNA viruses within the Picornaviridae family (StatPearls, 2023). This genus encompasses a diverse group of human pathogens, including polioviruses, coxsackieviruses, echoviruses, and rhinoviruses, which are responsible for a broad spectrum of diseases ranging from mild respiratory infections to severe conditions like aseptic meningitis, myocarditis, and paralytic poliomyelitis (NCBI, 2022). From a therapeutic perspective, Enterovirus is not a single molecular target but a pathogen genus containing several key proteins essential for viral survival and replication (Nature Reviews Microbiology, 2018). Primary molecular targets within the virus include the viral capsid (VP1-VP4), which mediates attachment and uncoating; the 3C protease (3Cpro), required for polyprotein processing; and the RNA-dependent RNA polymerase (3Dpol), which replicates the viral genome (PubMed, 2019). Antiviral agents such as pleconaril and rupintrivir have been designed to inhibit these specific viral functions, although the high genetic variability and rapid mutation rates of enteroviruses present significant hurdles for the development of broad-spectrum and durable therapies (Antiviral Research, 2013).
Capsid binding to prevent viral uncoating; Inhibition of viral 3C protease; Inhibition of RNA-dependent RNA polymerase.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enterovirus (EV).